Impact of Lipids on Insulin Resistance: Insights from Human and Animal Studies
Drug Design, Development and Therapy · 2024-07 · Volume 18 · 3337-3360
DOI: 10.2147/dddt.s468147 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2024-07. Verfasst von Rani Yulifah Elkanawati und 2 weiteren Autor:innen. Beteiligte Einrichtung: Master Program in Pharmacy, Faculty of Pharmacy, Padjadjaran University, Jawa Barat, West Java, 45363, Indonesia. Hauptthemen laut MEDLINE: Insulin Resistance. Die Arbeit wurde bisher 101-mal zitiert (Crossref) und nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Master Program in Pharmacy, Faculty of Pharmacy, Padjadjaran University, Jawa Barat, West Java, 45363, Indonesia.
- Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Padjadjaran University, Sumedang, West Java, 45363, Indonesia.
ORCID-Profile: Jutti Levita
Zitieren
APA
Elkanawati, R. Y., Sumiwi, S. A., & Levita, J. (2024). Impact of Lipids on Insulin Resistance: Insights from Human and Animal Studies. Drug Design, Development and Therapy, Volume 18, 3337-3360. https://doi.org/10.2147/dddt.s468147
Vancouver
Elkanawati RY, Sumiwi SA, Levita J. Impact of Lipids on Insulin Resistance: Insights from Human and Animal Studies. Drug Design, Development and Therapy. 2024;Volume 18:3337-3360. doi:10.2147/dddt.s468147
BibTeX
@article{Elkanawati2024,
author = {Elkanawati, Rani Yulifah and Sumiwi, Sri Adi and Levita, Jutti},
title = {Impact of Lipids on Insulin Resistance: Insights from Human and Animal Studies},
journal = {Drug Design, Development and Therapy},
year = {2024},
volume = {Volume 18},
pages = {3337--3360},
doi = {10.2147/dddt.s468147}
}
EUVIMED